Jon S Odorico, MD
- Section of Kidney and Pancreas Surgery
- Division of Transplantation
Clinical Science Center
600 Highland Avenue
Madison WI 53792
- MD, New York University, School of Medicine, New York, NY, 1987
- Residency, General Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, 1987-1994
- Postdoctoral Research Fellow, Harrison Department of Surgical Research, Hospital of the University of Pennsylvania, Philadelphia, PA, 1990-1992
- Fellow, Transplant Surgery, University of Wisconsin Hospital and Clinics, Madison, WI, 1994-1996
Dr. Odorico is certified by the American Board of Surgery. He specializes in pancreatic, islet cell, and multi-organ transplants.
Dr. Odorico’s research focuses on stem cell biology and differentiation, developing novel stem cell-based strategies for treating diabetes, pancreas transplantation, and islet cell transplantation.
Dr. Odorico’s lab
Conversion from Immediate Release Tacrolimus to Envarsus XR® in Simultaneous Pancreas-Kidney Recipients: Assessment of functional, safety and quality of life outcomes (CIRTEN SPK)
Study sponsor: University of Wisconsin-Madison
Study funding provided by: Veloxis Pharmaceuticals
Jon S. Odorico, MD, Principal Investigator
Non Invasive Blood Test to Diagnose Acute Rejection After Pancreas and Kidney Transplantation: Pancreas and Renal Rejection Diagnosis Using Circulating Donor-Derived Cell-free DNA in Peripheral Blood (PANCDx)
Study funding provided by: CareDx
Jon S. Odorico, MD, Sub-Investigator
Subcontract Agreement Amendment under negotiation, we expect to start enrollment in the first quarter of 2020
Large single center results of simultaneous pancreas-kidney transplantation in patients with type 2 diabetes.
Pham PH, Stalter LN, Martinez EJ, Wang JF, Welch BM, Leverson G, Marka N, Al-Qaoud T, Mandelbrot D, Parajuli S, Sollinger HW, Kaufman D, Redfield RR, Odorico JS
Am J Transplant 2020 Dec 22;
[PubMed ID: 33350048]
The Demise of Islet Allotransplantation in the US: A Call for an Urgent Regulatory Update The "ISLETS FOR US" Collaborative.
Witkowski P, Philipson L, Kaufman DB, Ratner L, Abouljoud MS, Bellin M, Buse J, Kandeel F, Stock P, Mulligan D, Markmann JF, Kozlowski T, Andreoni K, Alejandro R, Baidal D, Hardy MA, Wickrema A, Mirmira RG, Fung J, Becker Y, Josephson MA, Bachul PJ, Pyda JS, Charlton M, Millis JM, Gaglia J, Stratta RJ, Fridell JA, Niederhaus S, Forbes RC, Jayant K, Robertson RP, Odorico J, Levy M, Harland R, Abrams PL, Olaitan OK, Kandaswamy R, Wellen J, Japour AJ, Desai CS, Naziruddin B, Balamurugan AN, Barth RN, Ricordi C
Am J Transplant 2020 Nov 29;
[PubMed ID: 33251712]
Pancreas transplants from small donors: are the outcomes acceptable? A retrospective study.
Al-Qaoud TM, Odorico JS, Al-Adra DP, Kaufman DB, Sollinger HW, Leverson G, Welch B, Redfield RR
Transpl Int 2020 Aug 04;
[PubMed ID: 32749728]
Alloimmunity in pancreas transplantation.
Aziz F, Mandelbrot D, Parajuli S, Al-Qaoud T, Redfield R, Kaufman D, Odorico JS
Curr Opin Organ Transplant 2020 08; 25(4): 322-328
[PubMed ID: 32692039]
Outcomes of simultaneous pancreas and kidney transplants based on preemptive transplant compared to those who were on dialysis before transplant - a retrospective study.
Parajuli S, Swanson KJ, Patel R, Astor BC, Aziz F, Garg N, Mohamed M, Al-Qaoud T, Redfield R, Djamali A, Kaufman D, Odorico J, Mandelbrot DA
Transpl Int 2020 Sep; 33(9): 1106-1115
[PubMed ID: 32479673]